{"summary": "a combination of lopinavir/ritonavir and interferon-1b (IFN-1b) may be effective against MERS-CoV. the trial is initially designed to include 2 two-stage components. the first two-stage component is designed to adjust sample size and determine futility stopping, but not efficacy stopping. the second two-stage component is designed to determine efficacy stopping and possibly readjustment of sample size. edward et al."}